Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Giselle Balaciano joins MTRC as Evidence Synthesis Specialist

We are pleased to announce the appointment of Ms. Giselle Balaciano as Evidence Synthesis Specialist at MTRC. With nearly 20 years of experience in HTA methodology, clinical guideline development, and systematic reviews, Ms. Balaciano significantly strengthens MTRC’s capabilities in high-impact evidence generation and strategic support for market access and policy decision-making.

Since 2008, she has served as Methodology Advisor to the Argentinian Ministry of Health, leading national health technology assessments and GRADE-based clinical practice guidelines. Her work has directly influenced national healthcare policy and reimbursement decisions at the highest level.

As a trainer with Cochrane Argentina, Ms. Balaciano offers deep expertise in systematic reviews and meta-analysis, aligned with global methodological standards. Her portfolio includes contributions to over 100 systematic reviews and HTA reports, with publications in leading journals such as the Journal of Clinical EpidemiologyPLOS ONE and BMC Cardiovascular Disorders.

This appointment further reinforces MTRC’s position as a trusted partner in delivering rigorous, decision-relevant evidence across therapeutic areas and healthcare systems.

Organizations seeking high-quality HTA, systematic reviews, or guideline development support are invited to contact MTRC to explore collaboration.